Compare Bio Protocol (BIO) vs Golem (GLM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bio Protocol vs Golem — how do they compare? Bio Protocol trades at Rp441.84 (market cap Rp997,34M, Rp163,74M 24h volume), while Golem trades at Rp1,570 (market cap Rp1,57T, Rp74,77M 24h volume). The key difference: Golem is far larger — about 1574.2× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 1B / 1B GLM (100%) for Golem. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Golem for 19 Days on average.
| BIO | GLM | |
|---|---|---|
Market Cap | Rp997,34M | Rp1,57T |
Volume (24h) | Rp163,74M | Rp74,77M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 1B / 1B GLM (100%) |
Typical Hold Time | 18 Days | 19 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Golem (GLM) currently trades at Rp1,562 with a market cap of Rp1.56 trillion, showing bearish technical signals from moving averages despite oversold RSI readings. The token faces immediate resistance at Rp1,600 and support at Rp1,530. With 100% circulating supply and average hold time of 19 days, the network maintains full token distribution but shows relatively short-term holding patterns.
Overall outlook remains cautious with technical weakness prevailing. Key opportunities include potential oversold bounce from current levels, while major risks involve continued bearish momentum and limited fundamental catalysts. Investors should monitor network adoption metrics and trading volume recovery for signs of sustained recovery.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Bio Protocol
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →About Golem
Golem Network is an open-source, decentralized platform that provides computing power for the AI industry. It operates as a peer-to-peer marketplace where users exchange GLM tokens to rent or share idle computing resources.
Read more on GLM →
